We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for maribavir (Takeda Pharmaceuticals Australia Pty Ltd)
Active ingredients
maribavir
Date of review outcome
Lapse date
Type
Priority Review
Indication
For the treatment of adults with post-transplant CMV infection and disease resistant or refractory to one or more prior therapies
Therapeutic area
Infectious diseases